AAN循证指南静脉注射免疫球蛋白治疗神经肌肉疾病Intravenous+immunoglobulin+in+the+treatment+of+neuromuscular+disorders.pdf

Evidence-based guideline: Intravenous immunoglobulin in the treatment of neuromuscular disorders : Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology H.S. Patwa, V. Chaudhry, H. Katzberg, et al. Neurology 2012;78;1009 DOI 10.1212/WNL.0b013e31824de293 This information is current as of April 1, 2012 The online version of this article, along with updated information and services, is located on the World Wide Web at: /content/78/13/1009.full.html Neurology ® is the official journal of the American Academy of Neurology. Published continuously since 1951, it is now a weekly with 48 issues per year. Copyright © 2012 by AAN Enterprises, Inc. All rights reserved. Print ISSN: 0028-3878. Online ISSN: 1526-632X. SPECIAL ARTICLE Evidence-based guideline: Intravenous immunoglobulin in the treatment of neuromuscular disorders Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology H.S. Patwa, MD ABSTRACT V. Chaudhry, MD Objective: To assess the evidence for the efficacy of IV immunoglobulin (IVIg) to treat neuromus- H. Katzberg, MD cular disorders. A.D. Rae-Grant, MD Methods: The MEDLINE, Web of Science, and EMBASE databases were searched (1966–2009). Y.T. So, MD, PhD